252 related articles for article (PubMed ID: 23864685)
1. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
[TBL] [Abstract][Full Text] [Related]
2. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
[TBL] [Abstract][Full Text] [Related]
3. Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion.
Belaid H; Adrien J; Laffrat E; Tandé D; Karachi C; Grabli D; Arnulf I; Clark SD; Drouot X; Hirsch EC; François C
J Neurosci; 2014 Jul; 34(27):9124-33. PubMed ID: 24990932
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
Rolland AS; Tandé D; Herrero MT; Luquin MR; Vazquez-Claverie M; Karachi C; Hirsch EC; François C
J Neurochem; 2009 Aug; 110(4):1321-9. PubMed ID: 19527435
[TBL] [Abstract][Full Text] [Related]
5. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.
Pienaar IS; van de Berg W
Exp Neurol; 2013 Oct; 248():213-23. PubMed ID: 23769975
[TBL] [Abstract][Full Text] [Related]
6. Role of the pedunculopontine nucleus in controlling gait and sleep in normal and parkinsonian monkeys.
Karachi C; Francois C
J Neural Transm (Vienna); 2018 Mar; 125(3):471-483. PubMed ID: 28084536
[TBL] [Abstract][Full Text] [Related]
7. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.
Sharma PK; Wells L; Rizzo G; Elson JL; Passchier J; Rabiner EA; Gunn RN; Dexter DT; Pienaar IS
Neurotherapeutics; 2020 Jul; 17(3):1120-1141. PubMed ID: 31965550
[TBL] [Abstract][Full Text] [Related]
8. The pedunculopontine nucleus in Parkinson's disease: primate studies.
Nandi D; Jenkinson N; Stein J; Aziz T
Br J Neurosurg; 2008; 22 Suppl 1():S4-8. PubMed ID: 19085345
[TBL] [Abstract][Full Text] [Related]
9. Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?
Heise CE; Teo ZC; Wallace BA; Ashkan K; Benabid AL; Mitrofanis J
Anat Embryol (Berl); 2005 Nov; 210(4):287-302. PubMed ID: 16237536
[TBL] [Abstract][Full Text] [Related]
10. Levodopa affects spike and local field synchronisation in the pedunculopontine nucleus of a rat model of Parkinson's disease.
Zhang H; Xie J; Li Y; Liu H; Liu C; Kan D; Geng X; Wei S
Aging (Albany NY); 2021 Feb; 13(5):7314-7329. PubMed ID: 33639616
[TBL] [Abstract][Full Text] [Related]
11. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
[TBL] [Abstract][Full Text] [Related]
12. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.
Elson JL; Yates A; Pienaar IS
Brain Struct Funct; 2016 May; 221(4):2319-41. PubMed ID: 25989851
[TBL] [Abstract][Full Text] [Related]
13. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.
Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA
Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034
[TBL] [Abstract][Full Text] [Related]
14. Gait improvement by high-frequency stimulation of the subthalamic nucleus in Parkinsonian mice is not associated with changes of the cholinergic system in the pedunculopontine nucleus.
Witzig VS; Alosaimi F; Temel Y; Schulz JB; Jahanshahi A; Tan SKH
Neurosci Lett; 2023 Apr; 802():137134. PubMed ID: 36801348
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA.
Di Giovanni G; Chagraoui A; Puginier E; Galati S; De Deurwaerdère P
Neurobiol Dis; 2019 Aug; 128():9-18. PubMed ID: 30149181
[TBL] [Abstract][Full Text] [Related]
16. The role of the pedunculopontine tegmental nucleus in experimental parkinsonism in primates.
Matsumura M; Kojima J
Stereotact Funct Neurosurg; 2001; 77(1-4):108-15. PubMed ID: 12378066
[TBL] [Abstract][Full Text] [Related]
17. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
[TBL] [Abstract][Full Text] [Related]
18. Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
Xiao H; Li M; Cai J; Li N; Zhou M; Wen P; Xie Z; Wang Q; Chang J; Zhang W
Neurosci Lett; 2017 Oct; 659():92-98. PubMed ID: 28803956
[TBL] [Abstract][Full Text] [Related]
19. Deep brain stimulation of different pedunculopontine targets in a novel rodent model of parkinsonism.
Gut NK; Winn P
J Neurosci; 2015 Mar; 35(12):4792-803. PubMed ID: 25810510
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activity of the subthalamic nucleus in a primate model of L-dopa-unresponsive parkinsonism.
Fernagut PO; Barraud Q; Bezard E; Ghorayeb I; Tison F
Neurol Res; 2010 Dec; 32(10):1050-3. PubMed ID: 20810027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
